![Mark Wegter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Wegter
Directeur Général chez
LSP Advisory BV
Profil
Mark A. Wegter currently serves as Director-Supervisory Board at PamGene International BV and PamGene BV since 2000.
Since 1998, Mr. Wegter is Managing Partner at LSP Advisory BV.
Since 2022, Mr. Wegter is Partner at EQT Life Sciences Group BV.
Former positions include Director-Executive Board at 4-Antibody AG from 2010 to 2011, Director at VitrOmics Healthcare Holding BV, Director at European Biotech Acquisition Corp.
from 2021 to 2023, Member-Management Board at Kiadis Pharma BV from 2009 to 2012, and Member-Supervisory Board at Kiadis Pharma NV from 2001 to 2015.
Education includes a graduate degree from Erasmus University Rotterdam conferred in 1995.
Postes actifs de Mark Wegter
| Sociétés | Poste | Début |
|---|---|---|
LSP Management Group BV
 LSP Management Group BV Investment ManagersFinance EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million. | Private Equity Investor | 01/01/1998 |
PamGene BV
 PamGene BV Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products and clinical settings | Directeur/Membre du Conseil | 01/12/2000 |
PamGene International BV
 PamGene International BV Pharmaceuticals: MajorHealth Technology Provides biotechnology products for pharma and medical research | Directeur/Membre du Conseil | 14/10/2009 |
LSP Advisory BV
 LSP Advisory BV Investment ManagersFinance Provides investment advice | Directeur Général | 01/01/1998 |
Anciens postes connus de Mark Wegter
| Sociétés | Poste | Fin |
|---|---|---|
| EURO BIOT | Directeur/Membre du Conseil | 28/02/2023 |
VitrOmics Healthcare Holding BV
 VitrOmics Healthcare Holding BV Pharmaceuticals: MajorHealth Technology Operates as a holding company with interests in pharmaceutical manufacturing services | Directeur/Membre du Conseil | 01/01/2015 |
4-Antibody AG
 4-Antibody AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Corporate Officer/Principal | 01/01/2011 |
| KIADIS PHARMA N.V. | Président | - |
Kiadis Pharma BV
 Kiadis Pharma BV Pharmaceuticals: MajorHealth Technology Operates as a is a clinical stage biopharmaceutical company focused on research, development and future commercialization of cell based immunotherapy products | Président | - |
Formation de Mark Wegter
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
LSP Management Group BV
LSP Management Group BV Investment ManagersFinance EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million. | Finance |
PamGene International BV
PamGene International BV Pharmaceuticals: MajorHealth Technology Provides biotechnology products for pharma and medical research | Health Technology |
PamGene BV
PamGene BV Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products and clinical settings | Health Technology |
4-Antibody AG
4-Antibody AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Erasmus University Rotterdam
 Erasmus University Rotterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kiadis Pharma BV
Kiadis Pharma BV Pharmaceuticals: MajorHealth Technology Operates as a is a clinical stage biopharmaceutical company focused on research, development and future commercialization of cell based immunotherapy products | Health Technology |
VitrOmics Healthcare Holding BV
VitrOmics Healthcare Holding BV Pharmaceuticals: MajorHealth Technology Operates as a holding company with interests in pharmaceutical manufacturing services | Health Technology |
LSP Advisory BV
LSP Advisory BV Investment ManagersFinance Provides investment advice | Finance |
Kiadis Pharma NV
 Kiadis Pharma NV Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company focused on research, development and commercialization of cell based immunotherapy products | Health Technology |
European Biotech Acquisition Corp.
 European Biotech Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
